What is LOPJLB’s current signal on ATTO?

LOPJLB’s latest quantitative signal on Attovia Therapeutics, Inc. (ATTO) is FLAT. Signals are updated daily.

What market regime is ATTO in?

LOPJLB classifies each ticker into Bull, Recovery, Ranging, Bear, or Crisis regimes using a Hidden Markov Model.

What does Attovia Therapeutics, Inc. (ATTO) do?

A clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases using its ATTOBODY biologics platform. The company's lead candidate, ATTO-1310, targets interleukin-31 (IL-31), known as the 'itch cytokine,' for the treatment of chronic pruritic diseases including atopic dermatitis. Its pipeline also includes multi-specific candidates for other inflammatory dise…

Where is Attovia Therapeutics, Inc. based / listed?

Attovia Therapeutics, Inc. is based in US, listed on NASDAQ.

Attovia Therapeutics, Inc. (ATTO)

Healthcare · Biotechnology · NASDAQ · US

$20.80+2.92%Close

FLAT

[SCORES & PROFILE]

FUND: 8
VALUE: 0
GROWTH: 47
GARP: 7
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-15.3%

REV YoY-

ROE-25.5%

EPS YoY-

ROA-23.1%

GROSS

NET

[VALUATION]

P/E TTM-23.64

P/E FWD-

SECTOR PE22.60

INDUSTRY PE17.46

P/B6.04

P/FCF-

EV/EBITDA-24.01

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E3.62

ALTMAN Z-

CURR RATIO13.94

ND/EBITDA-

BETA0.00

NET INCOME (TTM) < 0

Attovia Therapeutics, Inc. (ATTO)

Key stats

Sector peers

Prediction markets

FUNDAMENTALS

Company news